AnnouncedFiled 2 July 2025
Syntis Bio, Inc. raised $25M
Syntis Bio, Inc., a biotech company based in Boston, MA, raised $25M in a new equity round, according to a filing dated 2 July 2025.
Announced on 1 July 2025, 1 day before the filing. syntis.bio ↗
- Filed
- 2 July 2025
- Round
- Equity round
- Amount sold
- $25M
- Offering size
- $26.5M
- Investors so far
- 12
- Based in
- Boston, MA
- Website
- syntis.bio
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
3 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 77% of the 1,404 tracked raises with an amount filed in 2025, and than 61% of the 112 in biotech.
Syntis Bio, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 2 Jul 2025 | New filing | $25M | This raise |
| 27 Jan 2025 | New filing | $6.32M | Another raise |
| 17 Jan 2023 | Amended filing | $15.4M | Another raise |
| 17 Aug 2022 | New filing | $11.2M | Another raise |
More with BOLD Capital Associates on the board
- Solarea Bio, Inc.$9.91M
- Gallant Pet, Inc.$10.2M
- Exo Imaging, Inc.$43.9M
- Viome Life Sciences, Inc.$25.4M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.